An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Johnson Controls International raised its 2025 profit forecast after beating second-quarter expectations on Wednesday, helped ...

In a pre-emptive purchase, 20 th Century Studios has muscled in on the rights to Ripped, a short story by Joe Ballarini for ...

Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full ...

Johnson & Johnson MedTech, Stryker and Zimmer Biomet lead MassDevice's annual list of the world's largest orthopedic device ...

It also acts as a reference point for analysts and investors. However, not all stocks within this elite group of companies ...

The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

At the end of Q4 2024, 18 billionaires held positions in Johnson & Johnson (NYSE:JNJ), worth over $2.9 billion collectively.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Johnson & Johnson (NYSE:JNJ) recently announced a 4.8% increase in its quarterly dividend and released positive Phase 3 clinical data for icotrokinra, an oral treatment for plaque psoriasis. These ...